PFPG
RPRX icon

Pinnacle Financial Partners (Georgia)’s Royalty Pharma RPRX Stock Holding History

Pinnacle Financial Partners (Georgia)’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.84M Sell
86,237
-377
-0.4% -$19.6K 0.03% 332
2026
Q1 		$4.15M Sell
86,614
-2,299
-3% -$101K 0.03% 335
2025
Q4 		$3.44M Buy
+88,913
New +$3.39M 0.03% 361

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Pinnacle Financial Partners (Georgia)'s RPRX Position: Q2 2026 in Review

Pinnacle Financial Partners (Georgia) reduced its Royalty Pharma (RPRX) stake by 0.44% in Q2 2026, selling an estimated $19.6K and leaving 86,237 shares worth $4.84M. The position accounts for 0.03% of the portfolio, ranked #332.

Pinnacle Financial Partners (Georgia) first reported a position in RPRX in Q4 2025 and has held it in 3 quarters since. 643 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

  • Pinnacle Financial Partners (Georgia) held 86,237 shares of Royalty Pharma worth $4.84M as of Q2 2026.
  • Pinnacle Financial Partners (Georgia) sold 377 Royalty Pharma shares in Q2 2026, an estimated $19.6K.
  • Royalty Pharma made up 0.03% of Pinnacle Financial Partners (Georgia)'s portfolio in Q2 2026, its #332 holding.
  • Pinnacle Financial Partners (Georgia) first reported a position in Royalty Pharma in Q4 2025 and has held it in 3 quarters since.
  • 643 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on Pinnacle Financial Partners (Georgia)'s 13F filing for Q2 2026, filed 14 Aug 2026.